Delivery Order SPE2DB20D9371-SPE2DB25FT1Z7
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for Stelara 90 mg/ml syringes with a ceiling value of $64,999.80. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and effective through November 2026. The award carries...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on July 18, 2025, for the supply of Stelara 90 mg/ml syringes. This delivery order was issued without a set-aside designation and is scheduled for completion by August 8, 2025, with performance taking place in Park Ridge, Illinois. The award represents a continuation of DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for $16,249.95 to supply Stelara 90 mg/mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 for Stelara 90 mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, carries no set-aside designation. This award represents a continuation of DMS Pharmaceutical Group's significant...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for Stelara 90 mg/mL syringes valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 15, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 8, 2025, represents a standard procurement action with no set-aside designation. The contract will be performed at the awardee's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- SPE2DB20D9371Indefinite Delivery Contract
- SPE2DB20D9371-SPE2DB25FT1Z7Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/mL syringes. This firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based on its established capabilities and pricing competitiveness. Performance of the work will take place at the contractor's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which carries a total value of $499,999,999 and remains valid through November 2026. The parent IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and specialty medications to support medical supply needs across Department of Defense healthcare facilities. Stelara, an immunosuppressant injectable medication, represents one of the specialized pharmaceutical products within the broader contract vehicle designed to serve military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/29/25 |